Tirzepatide Inj, 15mg x 4, Sterile Multi-Dose Vial, Rx only, Nomida, 25055 W Valley Pkwy, Suite 1...

FDA Recall #D-0395-2026 — Class II — February 26, 2026

Recall #D-0395-2026 Date: February 26, 2026 Classification: Class II Status: Ongoing

Product Description

Tirzepatide Inj, 15mg x 4, Sterile Multi-Dose Vial, Rx only, Nomida, 25055 W Valley Pkwy, Suite 106, Olathe, KS 66061, NDC 84223-002-04.

Reason for Recall

Lack of Assurance of Sterility

Recalling Firm

New Life Pharma LLC — Northvale, NJ

Classification

Class II — May cause temporary or medically reversible adverse health consequences.

Product Type

Drugs

Product Quantity

45 vials

Distribution

OH

Code Information

Lot 240709, exp 7/31/2026

Status

Ongoing

Voluntary / Mandated

Voluntary: Firm initiated